(Reuters) Billionaire investor Carl Icahn has taken a stake in Bristol-Myers Squibb Co and sees the drugmaker as a possible takeover target, according to a report published on Tuesday that sent the company’s shares from a loss to more than 2 percent higher. Earlier on Tuesday, Bristol-Myers said it added three directors to its board, a move supported by JANA Partners LLC, an activist investor building a stake in the company’s stock.
Bristol shares were down nearly 2 percent for much of the day before jumping as high as $57.21 after the Wall Street Journal said Icahn has built a large stake.
